Test Price
2,800 AED✅ Home Collection Available
HINT1 Gene Neuromyotonia and Axonal Neuropathy, Autosomal Recessive Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
Diagnostic Accuracy
99.9% analytical sensitivity via ISO 9001:2015 accredited NGS full-gene sequencing (Cert: INT/EGQ/2509DA/3139).
Collection Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM across Dubai and major UAE cities.
Post-Test Support
Telephonic genetic counseling session with a Consultant Medical Genetics specialist to interpret your result and outline clinical next steps.
Insurance & Billing
Direct billing verification and pre-authorization support via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The HINT1 Gene Genetic Test provides definitive molecular diagnosis of autosomal recessive neuromyotonia and axonal neuropathy by sequencing the entire coding region of the HINT1 gene. Our laboratory employs Next Generation Sequencing (NGS) with a bioinformatics pipeline validated against LC-MS/MS reference standards, delivering 99.9% sensitivity for detecting known pathogenic variants, novel mutations, and rare alleles. This approach exceeds the diagnostic yield of targeted genotyping panels by capturing full-gene coverage including intronic boundaries critical for splice-site variants.
| Feature | DNA Labs UAE – NGS Full Gene Sequencing | Alternative – Targeted Mutation Panel |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity; detects novel, rare, and all known pathogenic variants across entire HINT1 coding region plus flanking intronic regions. | Limited to a predefined set of common founder mutations; may miss up to 30% of causative variants in diverse populations. |
| Methodology | NGS with LC-MS/MS validated bioinformatics pipeline and Sanger confirmation for all clinically actionable variants. | Legacy Sanger sequencing of selected exons or multiplex ligation-dependent probe amplification (MLPA). |
| Turnaround & Regulatory | 3–4 weeks; full compliance with DHA licensing standards and Federal Decree-Law No. 45 of 2021 (PDPL) for genetic data protection. | May exceed 6 weeks; variable adherence to UAE genetic testing regulations and data privacy frameworks. |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I interpret every HINT1 variant within the framework of ACMG-AMP guidelines, integrating in-silico prediction models and population allele frequencies from gnomAD. A positive result confirms the molecular diagnosis, but careful segregation analysis in family members is essential for accurate recurrence risk counseling. I mandate that pre-test genetic counseling includes a three-generation pedigree and discussion of carrier implications for at-risk relatives. Our telephonic post-test session addresses reproductive options, including preimplantation genetic testing, and long-term neurological surveillance planning.”
⚠️ Clinical Medication Advisory
Do not alter or discontinue prescribed therapy without consulting your treating physician. Sodium channel blockers, anti-epileptics, and immunosuppressants used for symptomatic control of neuromyotonia must be adjusted only under direct medical supervision to avoid rebound hyperexcitability, laryngeal spasm, or cardiac arrhythmia.
🛡️ Patient Safety: Exclusion Criteria & Emergency Red Flags
Test Exclusion Criteria
- Inability to provide written informed consent or absence of a legal guardian signature for minors (mandated by Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Allogeneic hematopoietic stem cell transplant within the preceding 6 months, which may produce donor-derived chimerism in blood DNA.
- Active febrile illness or systemic infection; sample collection should be deferred until clinical resolution.
Emergency Red Flags – Seek Immediate Medical Attention
- Sudden onset respiratory difficulty or stridor suggestive of laryngeal spasm.
- Prolonged generalized muscle stiffness unresponsive to usual medication or status epilepticus.
- Signs of severe dysautonomia including cardiac arrhythmia, malignant hyperthermia, or unstable blood pressure.
Patient FAQ & Clinical Guidance
1. What is the diagnostic accuracy of the HINT1 NGS test for confirming neuromyotonia and axonal neuropathy?
This test delivers 99.9% analytical sensitivity by sequencing the full HINT1 coding region and conserved splice sites using a validated NGS platform. It identifies pathogenic missense, nonsense, frameshift, and splice-site variants with single-nucleotide resolution, enabling definitive molecular confirmation of autosomal recessive HINT1-related disease. The bioinformatics pipeline is cross-validated against LC-MS/MS reference data to eliminate false positives and ensure robust clinical reporting.
2. How is the home blood collection service conducted under UAE legal compliance?
Our DHA-licensed phlebotomists perform VIP home collection between 8 AM and 11 PM using a temperature-controlled, tamper-evident kit. The process adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. A pre-collection genetic counseling consent is completed at your residence, a pedigree chart is documented, and your sample is anonymized before ISO-certified transport to our laboratory.
3. What is the turnaround time and what happens after I receive my report?
Results are available within 3 to 4 weeks from sample receipt. Your report includes a detailed variant interpretation with ACMG-AMP classification, population frequency data, and clinical annotations. After delivery, you will receive a scheduled telephonic session with our Consultant Medical Genetics specialist to explain the findings, discuss inheritance patterns, and coordinate referrals for neurological evaluation, family screening, or reproductive genetic counseling as indicated.
UAE Regulatory & Data Privacy Adherence
Your genetic data is protected under UAE federal law. DNA Labs UAE complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, storage, and transfer of personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating health information systems and electronic medical records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring patient safety and informed consent standards in clinical testing.
Our laboratory is ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139) and holds DHA Facility License No. 1143, ensuring that every step from sample collection to result delivery meets the highest standards of quality, security, and ethical compliance.
Clinical & Logistical Metadata
| Test Name | HINT1 Gene Neuromyotonia and Axonal Neuropathy, Autosomal Recessive Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks (10–14 Business Days) |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Next Generation Sequencing (NGS) with LC-MS/MS validated bioinformatics pipeline; Sanger confirmation for all actionable variants |
| ICD-10-CM Code | G71.1, G60.0 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians